- Home
- NOTV vs CRML Comparison
NOTV vs CRML Comparison
Compare NOTV & CRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- CRML
- Stock Information
- Founded
- NOTV 1974
- CRML N/A
- Country
- NOTV United States
- CRML United States
- Employees
- NOTV N/A
- CRML N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- CRML
- Sector
- NOTV Health Care
- CRML
- Exchange
- NOTV Nasdaq
- CRML NYSE
- Market Cap
- NOTV 137.5M
- CRML 147.9M
- IPO Year
- NOTV 1997
- CRML N/A
- Fundamental
- Price
- NOTV $2.05
- CRML $2.49
- Analyst Decision
- NOTV Strong Buy
- CRML
- Analyst Count
- NOTV 1
- CRML 0
- Target Price
- NOTV $5.00
- CRML N/A
- AVG Volume (30 Days)
- NOTV 888.5K
- CRML 5.5M
- Earning Date
- NOTV 08-07-2025
- CRML 02-01-2025
- Dividend Yield
- NOTV N/A
- CRML N/A
- EPS Growth
- NOTV N/A
- CRML N/A
- EPS
- NOTV N/A
- CRML N/A
- Revenue
- NOTV $480,402,000.00
- CRML $476,979.00
- Revenue This Year
- NOTV $4.99
- CRML N/A
- Revenue Next Year
- NOTV $5.39
- CRML N/A
- P/E Ratio
- NOTV N/A
- CRML N/A
- Revenue Growth
- NOTV N/A
- CRML 326.80
- 52 Week Low
- NOTV $1.15
- CRML $1.23
- 52 Week High
- NOTV $6.48
- CRML $12.00
- Technical
- Relative Strength Index (RSI)
- NOTV 42.15
- CRML 62.35
- Support Level
- NOTV $2.64
- CRML $2.10
- Resistance Level
- NOTV $3.19
- CRML $2.98
- Average True Range (ATR)
- NOTV 0.33
- CRML 0.35
- MACD
- NOTV -0.09
- CRML 0.13
- Stochastic Oscillator
- NOTV 5.93
- CRML 51.77
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About CRML CRITICAL METALS CORPORATION
Critical Metals Corp is engaged in lithium exploration in Austria. It is focused on the development of its wholly-owned Wolfsberg Lithium Project (the Wolfsberg Project) located in Carinthia, Austria.